ARIA

ARIAD Pharmaceuticals, Inc. News Headlines

$7.2
*  
0.105
 negative 
1.48%
Get ARIA Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

ARIAD to Webcast Conference Call on First Quarter 2014 Financial Results
4/16/2014 7:35:00 AM - Business Wire

Clinical Study Initiations, Stock Price Updates, and Strategic Agreements - Analyst Notes on Ariad, Jazz, Intercept, Community Health, and United Technologies
4/2/2014 8:00:00 AM - PR Newswire

ARIAD Announces Appointment of Hugh Cole, Senior Pharmaceutical-Industry Executive, as Chief Business Officer
4/2/2014 7:35:00 AM - Business Wire

Technical Pointers on Top Gainers -- Research on ARIAD Pharma, Arotech, Restoration Hardware Holdings, and Sprouts Farmers Market
3/31/2014 12:52:00 PM - PR Newswire

ARIAD Announces Initiation of Pivotal Phase 2 ALTA Trial of AP26113 in Patients with Non-Small Cell Lung Cancer
3/24/2014 7:35:00 AM - Business Wire

Financial Results, Clinical Study Updates, Clinical Trial Results, Business Spin-Offs, and New Joint Ventures - Analyst Notes on ARIAD, NewLink, Puma Biotechnology, Theravance, and Ohr Pharmaceutical
3/12/2014 8:00:00 AM - PR Newswire

Most Active Equities Technical Snapshot: SandRidge Energy, Ariad Pharma, Groupon, and Vodafone
3/11/2014 10:12:00 AM - PR Newswire

New Appointments, Contract Extensions, Share Price Movements, Conference Schedules, and Closing of Public Offerings - Analyst Notes on Ariad, Novavax, Fonar, bluebird, and Cara
3/5/2014 7:24:00 AM - PR Newswire

ARIAD Reports 2013 Financial Results and Outlines Key Objectives for 2014
2/25/2014 7:35:00 AM - Business Wire

ARIAD to Present at the Cowen and Company 34th Annual Health Care Conference
2/24/2014 7:35:00 AM - Business Wire

ARIAD Expands Its Board of Directors with Appointment of Alexander J. Denner, Ph.D. of Sarissa Capital Management
2/21/2014 7:35:00 AM - Business Wire

ARIAD to Present at the RBC Capital Markets Healthcare Conference
2/19/2014 7:35:00 AM - Business Wire

ARIAD to Host Conference Call and Webcast Discussion of Fourth Quarter and Year-End 2013 Financial Results on February 25, 2014
2/10/2014 7:35:00 AM - Business Wire

ARIAD to Present at the Leerink Swann Global Healthcare Conference
2/5/2014 7:35:00 AM - Business Wire

ARIAD Announces Commercial Agreement for Iclusig (Ponatinib) in Australia
1/28/2014 7:35:00 AM - Business Wire